Menu
View Cart  

Recommended Products

Visit Store
Gmp-inspection-preparation-checklist-130x160

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological-risk-eval-and-mngmnt-for-md-130x160

Biological Risk Evaluation and Management for Medical Devices

Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.

Events

View All
May 30

Cutting the Costs of Clinical Trial Subject Recruitment: Insights into Patient Outreach: Traditio...

May 31

FDA’s New Concept of Operations for Drug Inspections and Evaluations: What You Need to Do Today

Jun 5

FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers

Jun 5

Appendix M of the NIH Guidelines: Reporting Requirements and Best Practices

Jun 6

10 Sure-Fire Tips for Developing a Document Management System Any Investigator Would Love

Jun 7

SOPs and Policies for the 21st Century: Why Less Is More

Editor's Picks

View all
Congress

Stakeholders Urge Congress to Update Clinical Laboratory Diagnostics Legislation

The letter to lawmakers cites an urgent need to reform regulations covering laboratory developed tests and in vitro diagnostics.
Moneyinhand2

Seniors Paying More for Generics Through Medicare Part D, Study Finds

The higher cost sharing did not correspond with an increase in the underlying price of generic drugs, Avalere said.

AETERNA ZENTARIS PRESENTED POSITIVE IN VIVO DATA ON ZEN-019, AN ORAL, LHRH ANTAGONIST PEPTIDOMIMETIC

KEYWORDS Daily International Pharma Alert
A A

AEterna Zentaris Inc. today announced that it presented Abstract No. P3-257 during a poster presentation entitled "ZEN-019, A Peptidomimetic from a New Class of Orally Active GnRH (LHRH) Antagonists," on Monday, June 26, 2006 in the Exhibit Hall of the Boston Convention & Exhibition Center in Boston, Massachusetts, during the 2006 Annual Meeting of the Endocrine Society.

Drug Newswire (http://www.drugnewswire.com/2696/)

Related Products

Assessing the Benefit-Risk Balance in Company Core Data Sheets - Webinar CD/Transcript

Data Integrity Problems On The Rise - Webinar CD/Transcript

Data Integrity Problems on the Rise - Webinar CD/Transcript

Related Events

The Real Impact of Common Rule in 2018: Understanding Nuances, Facilitating Compliance…

FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers

Advertising & Promotion Hot Topics in Today’s FDA and FTC Landscape: Do’s, Don’ts and Real-World Examples